• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感诊断学的最新进展:新型 H1N1 甲型流感大流行带来的启示。

Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic.

机构信息

Midwest Respiratory Virus Program, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

Clin Microbiol Rev. 2012 Apr;25(2):344-61. doi: 10.1128/CMR.05016-11.

DOI:10.1128/CMR.05016-11
PMID:22491775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3346302/
Abstract

The menu of diagnostic tools that can be utilized to establish a diagnosis of influenza is extensive and includes classic virology techniques as well as new and emerging methods. This review of how the various existing diagnostic methods have been utilized, first in the context of a rapidly evolving outbreak of novel influenza virus and then during the different subsequent phases and waves of the pandemic, demonstrates the unique roles, advantages, and limitations of each of these methods. Rapid antigen tests were used extensively throughout the pandemic. Recognition of the low negative predictive values of these tests is important. Private laboratories with preexisting expertise, infrastructure, and resources for rapid development, validation, and implementation of laboratory-developed assays played an unprecedented role in helping to meet the diagnostic demands during the pandemic. FDA-cleared assays remain an important element of the diagnostic armamentarium during a pandemic, and a process must be developed with the FDA to allow manufacturers to modify these assays for detection of novel strains in a timely fashion. The need and role for subtyping of influenza viruses and antiviral susceptibility testing will likely depend on qualitative (circulating subtypes and their resistance patterns) and quantitative (relative prevalence) characterization of influenza viruses circulating during future epidemics and pandemics.

摘要

可用于确诊流感的诊断工具种类繁多,包括经典病毒学技术以及新兴方法。本文综述了在新型流感病毒迅速暴发期间以及随后的大流行不同阶段和波次中,各种现有诊断方法的应用情况,展示了这些方法各自的独特作用、优势和局限性。在整个大流行期间,快速抗原检测得到了广泛应用。认识到这些检测的阴性预测值较低非常重要。具有快速开发、验证和实施实验室开发检测经验、基础设施和资源的私营实验室,在满足大流行期间的诊断需求方面发挥了前所未有的作用。获得 FDA 批准的检测方法仍然是大流行期间诊断工具包的重要组成部分,必须与 FDA 共同制定一个流程,以便制造商能够及时修改这些检测方法以检测新型菌株。流感病毒的亚型分析和抗病毒药敏检测的需求和作用可能取决于未来流行和大流行期间循环流感病毒的定性(循环亚型及其耐药模式)和定量(相对流行率)特征。

相似文献

1
Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic.流感诊断学的最新进展:新型 H1N1 甲型流感大流行带来的启示。
Clin Microbiol Rev. 2012 Apr;25(2):344-61. doi: 10.1128/CMR.05016-11.
2
Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response.检测 2009 年大流行性流感 A(H1N1)病毒感染:诊断检测的可及性促成了快速大流行应对。
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S36-43. doi: 10.1093/cid/ciq020.
3
Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection.快速免疫层析抗原检测在诊断 2009 年甲型 H1N1 流感病毒感染中的作用。
J Clin Microbiol. 2010 Jan;48(1):22-5. doi: 10.1128/JCM.02268-09. Epub 2009 Dec 9.
4
The evolving threat of influenza viruses of animal origin and the challenges in developing appropriate diagnostics.动物源性流感病毒的不断演变的威胁及其在开发适当诊断方法方面的挑战。
Clin Chem. 2012 Nov;58(11):1527-33. doi: 10.1373/clinchem.2012.182626. Epub 2012 Sep 11.
5
Evaluation of a new rapid test for the detection of influenza A and B viruses and pandemic (H1N1) 2009 virus subtyping in respiratory samples.评估一种用于检测呼吸道样本中甲型和乙型流感病毒及2009年甲型H1N1大流行性流感病毒亚型的新型快速检测方法。
J Med Microbiol. 2011 Sep;60(Pt 9):1403-1404. doi: 10.1099/jmm.0.030585-0. Epub 2011 Apr 1.
6
Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus.设计和性能的疾控中心实时逆转录聚合酶链反应猪流感小组检测 2009 年 A (H1N1) 流感大流行病毒。
J Clin Microbiol. 2011 Jul;49(7):2614-9. doi: 10.1128/JCM.02636-10. Epub 2011 May 18.
7
Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza.对四种快速抗原检测方法用于检测大流行 H1N1 2009 与季节性 H1N1 和 H3N2 甲型流感病毒的定量分析,比较其在流感患者鼻咽抽吸物中的应用。
J Virol Methods. 2012 Dec;186(1-2):184-8. doi: 10.1016/j.jviromet.2012.09.001. Epub 2012 Sep 7.
8
Clinical evaluation of rapid point-of-care testing for detection of novel influenza A (H1N1) virus in a population-based study in Spain.基于人群的西班牙研究中快速床边检测新型甲型流感(H1N1)病毒的临床评估。
Clin Microbiol Infect. 2010 Sep;16(9):1358-61. doi: 10.1111/j.1469-0691.2010.03159.x. Epub 2010 Feb 16.
9
Simultaneous detection of influenza A, influenza B, and respiratory syncytial viruses and subtyping of influenza A H3N2 virus and H1N1 (2009) virus by multiplex real-time PCR.采用多重实时 PCR 同时检测流感 A、流感 B 和呼吸道合胞病毒,并对流感 A H3N2 病毒和 H1N1(2009)病毒进行亚型分析。
J Clin Microbiol. 2011 Apr;49(4):1653-6. doi: 10.1128/JCM.02184-10. Epub 2011 Jan 26.
10
Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses.流感快速诊断检测对 H5N1 和 2009 年大流行 H1N1 病毒的敏感性。
J Clin Microbiol. 2010 Aug;48(8):2872-7. doi: 10.1128/JCM.00439-10. Epub 2010 Jun 16.

引用本文的文献

1
Modeling-based design of adaptive control strategy for the effective preparation of 'Disease X'.基于建模的适应性控制策略设计,用于有效防范“X疾病”。
BMC Med Inform Decis Mak. 2025 Feb 19;25(1):92. doi: 10.1186/s12911-025-02920-0.
2
State-Level Influenza Hospitalization Burden in the United States, 2022-2023.2022 - 2023年美国各州级流感住院负担
Am J Public Health. 2025 Apr;115(4):546-554. doi: 10.2105/AJPH.2024.307928. Epub 2025 Jan 30.
3
CRISPR-Based Assays for Point-of-Need Detection and Subtyping of Influenza.基于 CRISPR 的即时检测和流感亚型分析方法。
J Mol Diagn. 2024 Jul;26(7):599-612. doi: 10.1016/j.jmoldx.2024.04.004.
4
Agnostic Sequencing for Detection of Viral Pathogens.基于无信仰者测序的病毒病原体检测。
Clin Microbiol Rev. 2023 Mar 23;36(1):e0011922. doi: 10.1128/cmr.00119-22. Epub 2023 Feb 27.
5
Characterization of influenza infection in a high-income urban setting in Nairobi, Kenya.肯尼亚内罗毕一个高收入城市环境中流感感染的特征分析。
Trop Med Health. 2022 Sep 16;50(1):69. doi: 10.1186/s41182-022-00463-y.
6
CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus.基于CRISPR-Cas3的新冠病毒和流感病毒诊断方法
iScience. 2022 Feb 18;25(2):103830. doi: 10.1016/j.isci.2022.103830. Epub 2022 Jan 30.
7
Contribution of magnetic particles in molecular diagnosis of human viruses.磁性粒子在人类病毒分子诊断中的贡献。
Talanta. 2022 May 1;241:123243. doi: 10.1016/j.talanta.2022.123243. Epub 2022 Jan 21.
8
Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015-2016.2015-2016 年急性呼吸道疾病住院患儿的流感临床检测和奥司他韦治疗。
Influenza Other Respir Viruses. 2022 Mar;16(2):289-297. doi: 10.1111/irv.12927. Epub 2021 Oct 26.
9
Current state of commercial point-of-care nucleic acid tests for infectious diseases.传染病即时检测商用核酸检测的现状
Analyst. 2021 Apr 21;146(8):2449-2462. doi: 10.1039/d0an01988g. Epub 2021 Apr 7.
10
Nucleic Acid-Based Sensing Techniques for Diagnostics and Surveillance of Influenza.基于核酸的流感诊断和监测传感技术。
Biosensors (Basel). 2021 Feb 12;11(2):47. doi: 10.3390/bios11020047.

本文引用的文献

1
Population exposure to a novel influenza A virus over three waves of infection.人群在三次感染波中接触新型甲型流感病毒。
J Clin Virol. 2011 Dec;52(4):300-3. doi: 10.1016/j.jcv.2011.08.019. Epub 2011 Sep 15.
2
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.流感监测、诊断和疫苗评估的血清学检测。
Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83. doi: 10.1586/eri.11.51.
3
Systematic review of influenza resistance to the neuraminidase inhibitors.抗流感神经氨酸酶抑制剂耐药性的系统评价。
BMC Infect Dis. 2011 May 19;11:134. doi: 10.1186/1471-2334-11-134.
4
Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.A 和 B 型流感混合感染使对神经氨酸酶抑制剂敏感性改变的流感病毒的检测变得复杂。
Antiviral Res. 2011 Jul;91(1):20-2. doi: 10.1016/j.antiviral.2011.04.010. Epub 2011 Apr 23.
5
Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis.高分辨率熔解曲线分析技术对罕见变异敏感的方法用于检测耐药性大流行 2009(H1N1)流感 A 病毒的超灵敏检测
J Clin Microbiol. 2011 Jul;49(7):2602-9. doi: 10.1128/JCM.00277-11. Epub 2011 May 4.
6
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.血清学检测在检测美国人群中感染 2009 年甲型 H1N1 流感病毒中的敏感性和特异性。
J Clin Microbiol. 2011 Jun;49(6):2210-5. doi: 10.1128/JCM.00229-11. Epub 2011 Apr 6.
7
Multiplex PCR and emerging technologies for the detection of respiratory pathogens.多重 PCR 和新兴技术在呼吸道病原体检测中的应用。
Clin Infect Dis. 2011 May;52 Suppl 4(Suppl 4):S326-30. doi: 10.1093/cid/cir047.
8
Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens.用于呼吸道病原体分子检测的获得 FDA 批准/许可的诊断设备的优缺点。
Clin Infect Dis. 2011 May;52 Suppl 4(Suppl 4):S312-25. doi: 10.1093/cid/cir046.
9
A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.应用焦磷酸测序法和神经氨酸酶抑制试验检测奥司他韦耐药的大流行流感 A(H1N1) 2009 病毒的比较。
Antiviral Res. 2011 Apr;90(1):87-91. doi: 10.1016/j.antiviral.2011.02.014. Epub 2011 Mar 2.
10
Molecular diagnosis of viral respiratory infections.病毒呼吸道感染的分子诊断。
Curr Infect Dis Rep. 2011 Apr;13(2):149-58. doi: 10.1007/s11908-011-0168-x.